Moderna: The CEO Buys Shares Worth $5 Million. Ten new Products are Expected to be Launched by 2027. Rebound Opportunity!

Is it possible that things are not so bad behind the scenes at Moderna (MRNA)? The share price with its continuous decline suggests otherwise. However, there are some exciting developments. As recently reported, CEO Bancel purchased over 160,000 shares at $31.22. This amounts to a strong insider buy of over $5 million. This is a statement! There is no longer much speculation surrounding Moderna, but there are three reasons to keep an eye on the stock, which is predestined for a short-term rebound. 1.) By 2027, a total of ten new products based...